yttrium radioisotopes has been researched along with Lymphoma, Large B-Cell, Diffuse in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cassaday, RD; Chow, VA; Fisher, DR; Gooley, TA; Gopal, AK; Green, DJ; Maloney, DG; Matesan, M; Orozco, JJ; Press, OW; Sandmaier, BM; Smith, SD; Tuazon, SA | 1 |
| Arnason, JE; Avigan, D; Grant, B; Joyce, RM; Kim, M; Levine, J; Luptakova, K; Parker, JA; Rosenblatt, J; Tzachanis, D; Zwicker, JI | 1 |
| Cuzzocrea, S; Mian, M; Mondello, P; Navarra, M | 1 |
| Ansuinelli, M; Argnani, L; Bottelli, C; Broccoli, A; Cabras, MG; Casadei, B; Ciochetto, C; Gaidano, G; Gandolfi, L; Pellegrini, C; Stefoni, V; Zinzani, PL | 1 |
| Benjamin, H; Fenske, TS; Hohenwalter, EJ; Kroft, SH; Rilling, WS | 1 |
| Hamm, B; Jahnke, K; Kiewe, P; Korfel, A; Maza, S; Munz, DL; Thiel, E | 1 |
| Baldini, R; Cicone, F; Cox, MC; Russo, E; Scopinaro, F; Tofani, A; Torelli, F | 1 |
| Chung, JS; Kim, JS; Kim, SJ; Kim, WS; Kwak, JY; Lee, JJ; Oh, SY; Suh, C; Yang, DH | 1 |
| Hofman, MS; Wirth, A | 1 |
| Bradt, BM; Chan, K; DeNardo, GL; DeNardo, SJ; Tobin, E | 1 |
| Blau, IW; Fietz, T; Gentilini, C; Glass, B; Marinets, O; Muessig, A; Munz, DL; Rieger, K; Sandrock, D; Thiel, E; Uharek, L | 1 |
| Hess, G; Huglo, D; Illidge, T; Kalmus, J; Liberati, AM; Marcus, R; Martinelli, G; Milpied, N; Morschhauser, F; Paganelli, G; Rule, S; Stein, H; Zinzani, PL | 1 |
| Falk, P; Forman, SJ; Fung, HC; Krishnan, A; Molina, A; Nademanee, A; Palmer, JM; Raubitschek, AA; Rodriguez, R; Spielberger, RT; Yamauchi, D | 1 |
| Alinari, L; Baccarani, M; Bacci, F; Castellucci, P; de Vivo, A; Derenzini, E; Fanti, S; Farsad, M; Fina, M; Marchi, E; Musuraca, G; Pellegrini, C; Pileri, S; Stefoni, V; Tani, M; Zinzani, PL | 1 |
| Huijgens, PC; Jonkhoff, AR; Martens, HJ; Ossenkoppele, GJ; Teule, GJ; van Dieren, EB; Versteegh, RT | 1 |
1 review(s) available for yttrium radioisotopes and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityr.
Topics: Antibodies, Monoclonal; Humans; Lymphoma, Large B-Cell, Diffuse; Prognosis; Radioimmunotherapy; Yttrium Radioisotopes | 2016 |
6 trial(s) available for yttrium radioisotopes and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma.
Topics: Antibodies, Monoclonal; Humans; Lymphoma, Large B-Cell, Diffuse; Transplantation, Homologous; Yttrium Radioisotopes | 2022 |
First report on a prospective trial with yttrium-90-labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Central Nervous System Neoplasms; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radioimmunotherapy; Remission Induction; Survival Rate; Tissue Distribution; Yttrium Radioisotopes | 2009 |
Pilot trial of yttrium-90 ibritumomab tiuxetan consolidation following rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone chemotherapy in patients with limited-stage, bulky diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Pilot Projects; Prednisolone; Survival Rate; Treatment Outcome; Vincristine; Young Adult; Yttrium Radioisotopes | 2012 |
Efficacy and safety of yttrium-90 ibritumomab tiuxetan in patients with relapsed or refractory diffuse large B-cell lymphoma not appropriate for autologous stem-cell transplantation.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Survival Analysis; Yttrium Radioisotopes | 2007 |
Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Radioimmunotherapy; Stem Cell Transplantation; Treatment Outcome; Yttrium Radioisotopes | 2008 |
A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Feasibility Studies; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Prognosis; Prospective Studies; Radioimmunotherapy; Remission Induction; Thrombocytopenia; Treatment Outcome; Vincristine; Yttrium Radioisotopes | 2008 |
8 other study(ies) available for yttrium radioisotopes and Lymphoma, Large B-Cell, Diffuse
| Article | Year |
|---|---|
Yttrium-90 ibritumomab tiuxetan followed by rituximab maintenance as treatment for patients with diffuse large B-cell lymphoma are not candidates for autologous stem cell transplant.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Disease-Free Survival; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Remission Induction; Rituximab; Salvage Therapy; Survival Rate; Thrombocytopenia; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2015 |
Short-course R-CHOP followed by (90)Y-Ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients: 7-year long-term results.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Radioimmunotherapy; Rituximab; Survival Analysis; Treatment Outcome; Vincristine; Yttrium Radioisotopes | 2016 |
Treatment of diffuse large B-cell lymphoma of the liver with yttrium-90 microsphere embolization.
Topics: Adult; Antigens, CD20; Biomarkers, Tumor; Biopsy; Diagnosis, Differential; Embolization, Therapeutic; Fatal Outcome; Humans; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Microspheres; Palliative Care; Yttrium Radioisotopes | 2008 |
Radioimmunotherapy of heavily pre-treated, non-Hodgkin's lymphoma patients: efficacy and safety in a routine setting.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Radioimmunotherapy; Retrospective Studies; Rituximab; Yttrium Radioisotopes | 2009 |
Special delivery: getting radiation to the target in diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphoma, Large B-Cell, Diffuse; Yttrium Radioisotopes | 2012 |
Direct antilymphoma effects on human lymphoma cells of monotherapy and combination therapy with CD20 and HLA-DR antibodies and 90Y-labeled HLA-DR antibodies.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coloring Agents; Combined Modality Therapy; Dose-Response Relationship, Immunologic; HLA-DR Antigens; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Mice; Microscopy, Fluorescence; Radioimmunotherapy; Radiopharmaceuticals; Time Factors; Treatment Outcome; Trypan Blue; Yttrium Radioisotopes | 2005 |
Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.
Topics: Adult; Antibodies, Monoclonal; Antineoplastic Agents; Cyclophosphamide; Disease Progression; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Male; Radioimmunotherapy; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine; Yttrium Radioisotopes | 2006 |
Gallium-67 radiotoxicity in human U937 lymphoma cells.
Topics: Cell Division; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Neoplastic Stem Cells; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Yttrium Radioisotopes | 1993 |